Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.
Angelopoulou
Maria K
MK
Pangalis
Gerassimos A
GA
Sachanas
Sotirios
S
Kokoris
Styliani I
SI
Anargyrou
Konstantinos
K
Galani
Zaharoula
Z
Kalpadakis
Christina
C
Vassilakopoulos
Theodoros P
TP
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use* / Q000633:toxicity; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab